Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05102864 · ClinicalTrials.gov registry record · NA

A Trial of Two-Week Brain Stimulation for Teenagers With ADHD

A NA study of ADHD, sponsored by Bradley Hospital.

Active
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT05102864 is a NA study of ADHD that is active but no longer recruiting, run by Bradley Hospital. The registered enrollment target is 25 participants, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05102864, a NA study of ADHD, is active but no longer recruiting, sponsored by Bradley Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The objective of this clinical trial is to examine whether non-invasive brain stimulation can modulate dysfunctional brain dynamics underlying adolescent ADHD to subsequently improve clinical symptoms.

Conditions Studied

Interventions

  • DEVICE Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex

Study Locations (1)

Rhode Island

  • E. P. Bradley Hospital - East Providence

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2021-10-01
Est. Completion 2026-10-01
Phase NA

Sponsor

Bradley Hospital

12 total trials

What the Registry Record Tells You About NCT05102864

The ClinicalTrials.gov registry entry for NCT05102864 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (87% lower). The listed sponsor is Bradley Hospital, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 1 intervention - of which Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex is the first listed.

NCT05102864 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT05102864 about?

NCT05102864 is a clinical study titled "A Trial of Two-Week Brain Stimulation for Teenagers With ADHD". The objective of this clinical trial is to examine whether non-invasive brain stimulation can modulate dysfunctional brain dynamics underlying adolescent ADHD to subsequently improve clinical symptoms.

What is the current status of trial NCT05102864?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2021-10-01. Estimated completion is 2026-10-01.

What conditions does trial NCT05102864 study?

This clinical trial studies the following conditions: ADHD.

What interventions are being tested in trial NCT05102864?

The interventions under investigation include: Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex (DEVICE).

Who is sponsoring clinical trial NCT05102864?

This trial is sponsored by Bradley Hospital, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05102864 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ADHD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.